Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population-Reference-Cited by-同舟云学术

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population

Published:2015-01 Issue:1 Volume:21 Page:89-96
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Brammer Jonathan E.,Stentz Alexander,Gajewski James,Curtin Peter,Hayes-Lattin Brandon,Kovacsovics Tibor,Leis Jose F.,Meyers Gabrielle,Nemecek Eneida,Subbiah Nan,Frires Rachel,Palmbach Gundula,Avraham Galit Perets,Slater Susan,Maziarz Richard T.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference24 articles.

1. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects;McSweeney;Blood,2001

2. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age;Alyea;Blood,2005

3. Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives;Sandmaier;Biol Blood Marrow Transplant,2007

4. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors;Diaconescu;Blood,2004

5. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS;de Lima;Blood,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spleen-targeted delivery systems and strategies for spleen-related diseases;Journal of Controlled Release;2024-06

2. Outpatient allogeneic hematopoietic stem-cell transplantation: a review;Therapeutic Advances in Hematology;2022-01

3. Conditioning Regimens;Blood and Marrow Transplant Handbook;2021

4. Graft-Versus-Host Disease (GvHD) Prophylaxis;Blood and Marrow Transplant Handbook;2021

5. Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years;Hematology/Oncology and Stem Cell Therapy;2019-06